View abstract

Cet abstract a été assigné à session AOB Free Papers
Type de présentationOral presentation
TitreRuthenium Brachytherapy in eye tumors
ButBetween 2019 and 2013, 214 applications with Ruthenium brachytherapy in Leuven University Hospital. This study audits the indications, results, and the rates of local and distal metastases.
MéthodesRetrospective study
RésultatsOf 214 applications, 25 were conjunctival melanomas, 11 squamous cell carcinomas, 3 metastases, 2 hemangiomas, and 1 sacroma. The other 172 were uveal melanomas. Different sizes of plaques were used: 92 CCA, 91 CCB, 26 COB (for juxtapapillary tumors) and 5 CCC.
111 right eyes, and 100 males. Mean age at diagnosis was 66 years.
ConclusionRuthenium brachytherapy is a good and safe treatment for uveal and conjunctival melanomas, and can be very effective voor squamous cell carcinomas, large hemangiomas and metastases.
Conflit d'intérêtNon
Auteur 1
NomMISSOTTEN
InitialesG
InstitutJessa Oogkliniek Hasselt and University Hospitals Leuven
VilleHasselt/Leuven
Auteur 2
NomVan Calster
InitialesJ
InstitutLeuven University Hospitals
VilleLeuven
top ^